Part 2 of our conversation with Craig Lipset continues on the People Always, Patients Sometimes podcast. We look ahead to the future for clinical trials, pharmaceutical drug development, and, Craig himself. We asked him how the patient role in drug development has changed over time and where he sees it trending in the next five years.
Craig Lipset is a recognized leader at the forefront of innovation in clinical research and the drug development space. He’s an advisor to technology and biopharmaceutical companies, leading universities and the venture community bringing vision and driving action at the intersection of research, digital solutions and patient engagement. He was the Head of Clinical Innovation at Pfizer and on the founding operations committee for Transcelerate Biopharma.
Now, our conversation continues on People Always, Patients Sometimes.